Ramsay Hunt Syndrome is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Ramsay Hunt syndrome (RHS), also known as herpes zoster oticus or herpetic geniculate ganglionitis, is a neurological disorder caused by reactivation of the varicella-zoster virus (VZV) that affects the facial nerve (cranial nerve VII). The syndrome is characterized by facial paralysis, ear pain, and a vesicular rash in the external auditory canal or on the soft palate[1].
Ramsay Hunt syndrome is the second most common cause of atraumatic facial paralysis, accounting for approximately 7-12% of all facial palsy cases. It results from reactivation of the varicella-zoster virus (the same virus that causes chickenpox and shingles) in the geniculate ganglion of the facial nerve[2]. Following primary VZV infection (chickenpox), the virus remains dormant in sensory ganglia and can reactivate decades later, typically in immunocompromised individuals or the elderly[3].
The syndrome was first described by James Ramsay Hunt in 1907, who recognized the association between facial paralysis and herpes zoster infection of the ear[4].
The varicella-zoster virus establishes latency in the geniculate ganglion of the facial nerve following primary infection. Reactivation can occur due to:
Upon replication, the virus causes inflammatory changes in the facial nerve, leading to:
The facial nerve is particularly vulnerable because it passes through the narrow facial canal, where swelling can cause compression and ischemia[5].
| Symptom | Description | Frequency |
|---|---|---|
| Facial paralysis | Peripheral (lower motor neuron) palsy affecting one side | 100% |
| Ear pain | Severe otalgia, often preceding rash | ~90% |
| Vesicular rash | Herpetic blisters in ear canal, outer ear, or soft palate | ~75% |
| Hearing loss | Sensorineural or conductive hearing loss | ~40% |
| Vertigo | True rotational vertigo | ~30% |
| Tinnitus | Ringing in the affected ear | ~20% |
The facial nerve controls muscles of facial expression. Involvement leads to:
Diagnosis is primarily clinical, based on:
| Test | Purpose |
|---|---|
| PCR testing | Detects VZV DNA in vesicular fluid or cerebrospinal fluid |
| Serology | Shows rise in VZV IgM or fourfold rise in IgG |
| Electromyography (EMG) | Assesses facial nerve function and prognosis |
| MRI with contrast | Rules out other causes, may show facial nerve enhancement |
Early antiviral treatment is crucial for optimal outcomes:
Antiviral therapy should be initiated within 72 hours of symptom onset for maximum efficacy[6].
Systemic corticosteroids (prednisone 1mg/kg/day for 5-7 days, tapered) are commonly prescribed to reduce inflammation and minimize nerve damage. Combination therapy (antiviral + steroid) shows better outcomes than either treatment alone[7].
Current research focuses on:
The study of Ramsay Hunt Syndrome has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
This section highlights recent publications relevant to this disease.